Pradaxa and Bleeding disorders - a phase IV clinical study of FDA data
Bleeding disorders is found among people who take Pradaxa, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Pradaxa and have Bleeding disorders. It is created by eHealthMe based on reports of 83,867 people who have side effects when taking Pradaxa from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
83,867 people reported to have side effects when taking Pradaxa.
Among them, 1,448 people (1.73%) have Bleeding disorders.
What is Pradaxa?
Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 84,716 Pradaxa users for its effectiveness, alternative drugs and more.
What is Bleeding disorders?
Bleeding disorders is found to be associated with 2,223 drugs and 1,575 conditions by eHealthMe.
Number of Pradaxa and Bleeding disorders reports submitted per year:
Time on Pradaxa when people have Bleeding disorders *:
Gender of people who have Bleeding disorders when taking Pradaxa*:
Age of people who have Bleeding disorders when taking Pradaxa *:
Common drugs people take besides Pradaxa *:
Common side effects people have besides Bleeding disorders *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Pradaxa and have Bleeding disorders?Check whether Bleeding disorders is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Bleeding disorders and when was it recovered:
Expand to all the drugs that have ingredients of dabigatran etexilate mesylate:
Alternative drugs to, pros and cons of Pradaxa:
- Pradaxa (84,716 reports)
Common Pradaxa side effects:
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4,370 reports
- Death: 2,662 reports
- Dizziness: 2,453 reports
- Breathing difficulty: 2,409 reports
Browse all side effects of Pradaxa:a b c d e f g h i j k l m n o p q r s t u v w x y z
Bleeding disorders treatments and more:
- Bleeding disorders (22,302 reports)
COVID vaccines that are related to Bleeding disorders:
- Bleeding disorders in Moderna COVID Vaccine
- Bleeding disorders in Pfizer BioNTech Covid Vaccine
- Bleeding disorders in Johnson and Johnson Covid Vaccine
Common drugs associated with Bleeding disorders:
- Aspirin: 1,530 reports
- Pradaxa: 1,448 reports
- Xarelto: 1,250 reports
- Coumadin: 1,167 reports
- Lasix: 969 reports
- Prednisone: 904 reports
- Furosemide: 797 reports
- Methotrexate: 756 reports
- Lisinopril: 737 reports
- Omeprazole: 674 reports
All the drugs that are associated with Bleeding disorders:
- Bleeding disorders (2,223 drugs)
Common conditions associated with Bleeding disorders:
- Atrial fibrillation/flutter: 2,456 reports
- Stroke: 855 reports
- High blood pressure: 805 reports
- Pain: 616 reports
All the conditions that are associated with Bleeding disorders:
- Bleeding disorders (1,575 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on dabigatran etexilate mesylate (the active ingredients of Pradaxa) and Pradaxa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zide and Type 1 Diabetes - a second ago
- Clopidogrel and Hizentra drug interaction - 2 seconds ago
- Levoleucovorin Calcium and Pancreatitis Aggravated - 14 seconds ago
- Midodrine Hydrochloride and Ativan drug interaction - 27 seconds ago
- Polymyalgia Rheumatica and Sepsis - 35 seconds ago
- Isoptin and Paronychia - 37 seconds ago
- Ludiomil and Progesterone drug interaction - 37 seconds ago
- Cellcept and Meningitis Viral - 40 seconds ago
- Zinc Sulfate and Detrol La drug interaction - 44 seconds ago
- Oxycodone and Dermatitis Infected - 45 seconds ago